Global Stock News

  • March 4, 2026
Facebook-f X-twitter Linkedin-in Instagram

Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome

Article feature image

Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome

  • Business combination transaction with Arya Sciences Acquisition Corp III, a special purpose acquisition company sponsored by Perceptive Advisors, closed on June 9, 2021
  • Publicly traded company renamed Nautilus Biotechnology, Inc.
  • Common stock commences…

Click here to view the original article.

Share this article

More News

Scroll to Top